Enrofloxacin,Ciprofloxacin anticorps

N° du produit ABIN111400

Cet anticorps Souris Monoclonal détecte spécifiquement Enrofloxacin,Ciprofloxacin dans EIA. Il présente une réactivité avec des échantillons de Campylobacter.

Aperçu rapide pour Enrofloxacin,Ciprofloxacin anticorps (ABIN111400)

Antigène: Enrofloxacin,Ciprofloxacin

Reactivité: Campylobacter

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: Enzyme Immunoassay (EIA)

Clone: 72FIG1F7#1

Détail du produit

Purification: Purified

Immunogène: Enrofloxacin conjugated to KLH (keyhole limpet hemocyanin) via carbodiimide

Isotype: IgM

Information d'application

Indications d'application: Suitable for use in ELISA.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Concentration: 1.0 mg/mL (OD280 nm)

Buffer: PBS buffer, pH 7.4 without preservatives

Agent conservateur: Without preservative

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détail du antigène

Antigène: Enrofloxacin,Ciprofloxacin

Sujet: Enrofloxacin is a fluoroquinolone that inhibits the activity of bacterial DNA gyrase. It was the first fluoroquinolone antimicrobial to be used in veterinary infections by E. coli, Salmonella, Pasteurella, Mycoplasma and Hemophilus species. Ciprofloxacin, a fluoroquinolone, is a concentration dependent bactericidal agent. It is structurally related to enrofloxacin, and has a similar spectrum of activity. Both of these antimicrobials have shown activity against some gram positive aerobes and a wide range of gram negative bacilli and cocci, which include Klebsiella, Pseudomonas, Salmonella, and other organisms such as Mycoplasma, Staphylococci and Chlamydia. Due to the fluoroquinolone's variable activity against most Streptococci, as well as their weak activity against many anaerobic bacteria, they are generally not recommended for use in treating infections where these types of microbes are present. Like enrofloxacin, ciprofloxacin is believed to act by inhibiting bacterial DNA gyrase which prevents DNA supercoiling and DNA synthesis.